4-5015176-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018659.3(CYTL1):c.386C>T(p.Thr129Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000223 in 1,613,860 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018659.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYTL1 | NM_018659.3 | c.386C>T | p.Thr129Met | missense_variant | 4/4 | ENST00000307746.9 | NP_061129.1 | |
CYTL1 | XM_017008299.2 | c.*36C>T | 3_prime_UTR_variant | 5/5 | XP_016863788.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYTL1 | ENST00000307746.9 | c.386C>T | p.Thr129Met | missense_variant | 4/4 | 1 | NM_018659.3 | ENSP00000303550 | P1 | |
CYTL1 | ENST00000509419.1 | c.254C>T | p.Thr85Met | missense_variant | 3/3 | 3 | ENSP00000421743 | |||
CYTL1 | ENST00000506508.1 | c.206C>T | p.Thr69Met | missense_variant | 2/2 | 3 | ENSP00000425397 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152178Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251228Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135744
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1461564Hom.: 0 Cov.: 31 AF XY: 0.0000220 AC XY: 16AN XY: 727054
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152296Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74458
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 16, 2023 | The c.386C>T (p.T129M) alteration is located in exon 4 (coding exon 4) of the CYTL1 gene. This alteration results from a C to T substitution at nucleotide position 386, causing the threonine (T) at amino acid position 129 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at